Isabelle de Cremoux

Isabelle de Cremoux is a seasoned executive with extensive experience in the life sciences sector and capital investment. Currently serving as président du directoire / CEO at Seventure Partners since January 2014, Isabelle had previously held the position of CEO and lifesciences department director since October 2011. Isabelle also presides over the Capital Investment Commission for the French Asset Management Association (AFG), working to enhance the capital investment landscape in France. Additional roles include serving as a qualified personality for the French government's "Conseil de l'innovation," a board member at Naturex, and an independent board member at COMIGEL. Isabelle's career includes significant positions at Laboratoires Fournier, Pfizer France, and arthur andersen/EY. Isabelle holds a degree from CentraleSupélec and has completed DECF at ISEB.